DaiTongXiao improves gout nephropathy by inhibiting inflammatory response through the TLR4/MyD88/NF-κB pathway
Feifan Liu(University of Massachusetts Chan Medical School), Peixin Guo(Yunnan University)
Cited by 3
Related Papers
Generalisable long COVID subtypes: findings from the NIH N3C and RECOVER programmes
|EBioMedicine|2022|176
Reproducible variability: assessing investigator discordance across 9 research teams attempting to reproduce the same observational study
|Journal of the American Medical Informatics Association|2023|12
Mechanisms of Yajieshaba in the treatment of liver fibrosis through the Keap1-Nrf2 signaling pathway
|Frontiers in Pharmacology|2023|4